Prevalence of end stage renal disease in diabetic obese and hypertensive patients and cardiovascular risk in dialysis patients
Journal: Pakistan Journal of Pharmaceutical Research (Vol.2, No. 1)Publication Date: 2016-01-01
Authors : Muhammad Hanif; Hina Javed; Nazar Muhammad Ranjha; Umair Jillani;
Page : 42-48
Keywords : Chronic kidney disease; ESRD; obesity; hypertension; GFR; creatinine clearance; cardiac vascular death;
Abstract
Chronic Kidney Disease (CKD) is cause of irreversible deterioration in renal function which leads to end stage renal disease (ESRD). Incidence of end-stage renal disease has increased dramatically during the last 30 years and screening for early stages of chronic kidney disease is often suggested as a preventive measure. The main causes of end stage renal disease are diabetes, high blood pressure, hyperlipidemia and obesity. Obesity and increased BMI are the cause of kidney stone and chronic kidney disease. This report aims to determine the prevalence of end stage renal disease in diabetic obese individuals and other problems that are more likely to be encountered in end stage renal disease are cardiovascular risks in dialysis patients. GFR and Creatinine clearance are used as major diagnostic tool to determine kidney function. Calcium level is also used as the predictive factor to determine the vascular calcification.
Other Latest Articles
- Cost-minimization analysis of various pharmaceutical alternatives of clopidogrel bisulfate
- Prevalence of Asthma in Southern Punjab, Pakistan
- Development and application of spectrophotometric method for quantitative determination of Metronidazole in pure and tablet formulations
- Biological activity of Terminalia arjuna on Human Pathogenic Microorganisms
- Dapoxetine: An Innovative Approach in the Therapeutic Management in Animal Model of Depression
Last modified: 2021-03-06 18:15:47